Integrated DNA technologies INC:1107504 [13-015790]
Ended Awarded Last action
- Contract number
- HHSN26900001
- Awardee
-
Integrated DNA Technologies, Inc. UEI P55FTN1UMYZ1
- Awarding agency
-
Office of the Chief Operating Officer
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,854
Award facts
- Contract value 33% obligated
-
- $4,853.75 Current, with exercised options
- $14,853.75 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 4 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Skokie, IL 60076, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$146 | |
| Other Administrative Action | $0 | |
| Original award | $5,000 |
About this award
This contract was awarded to Integrated DNA Technologies, Inc. (IDT), a leading manufacturer and supplier of specialized nucleic acid products and services to the U.S. federal government. The contract is a Blanket Purchase Agreement (BPA) call with a ceiling value of $14,853.75 and a completion date of September 8, 2014. The funding agency is the Office of the Chief Operating Officer, a civilian agency. IDT has provided custom oligonucleotides, antisense oligonucleotides, DNA library kits, exome panels, and specialized reagents for various federal research projects, including those related to COVID-19, genetic sequencing, neurodegenerative disorders, marine genetics, and advanced diagnostic development. The contract does not have a set-aside designation, indicating IDT competes effectively in the open market. IDT maintains several significant federal contract Indefinite Delivery Vehicles (IDVs), including a $5 million BPA with the Defense Health Agency and a $10 million BPA with the National Institute of Neurological Disorders and Stroke, demonstrating the company's capacity to support diverse federal needs in genomics, molecular biology, and research applications.
Quick answers
Who was awarded contract HHSN26900001?
HHSN26900001 was awarded to Integrated DNA Technologies, Inc. by Office of the Chief Operating Officer (National Institutes of Health) on September 6, 2013.
How much is contract HHSN26900001 worth?
The government has obligated $4,854 on HHSN26900001. Its potential value, with all options, is $14,854.
Is contract HHSN26900001 an order under another contract?
Yes. HHSN26900001 is a BPA call under HHSN263200400060954B, a blanket purchase agreement.
Was contract HHSN26900001 competed?
The extent of competition for HHSN26900001 was competed under sap. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award